NCT06608576 (BBL-ATOP) is a NA clinical trial of Face-to-face standard treatment in High-risk Infants, sponsored by Universidad de Granada.

Who is sponsoring NCT06608576?

NCT06608576 is sponsored by Universidad de Granada.

What drugs are being tested in NCT06608576?

Interventions in NCT06608576: Face-to-face standard treatment, Telematic Support.

What condition does NCT06608576 study?

NCT06608576 studies High-risk Infants.

Is NCT06608576 still recruiting?

NCT06608576 is currently enrolling by invitation. Last updated 23 September 2024.

Last reviewed 2024-09-23 · How we verify

NCT06608576: BBL-ATOP

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Telematic Support in Early Intervention on Infants At Risk of Neurodevelopmental Delays

ENROLLING BY INVITATION NA Last updated 23 September 2024

What this trial tests

NA trial testing Face-to-face standard treatment in High-risk Infants in 60 participants. Enrolling by invitation.

Timeline

15 February 2024

Primary endpoint
31 July 2025

31 July 2025

Quick facts

Lead sponsor	Universidad de Granada
Phase	NA
Status	ENROLLING BY INVITATION
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	supportive care
Enrollment	60
Start date	15 February 2024
Primary completion	31 July 2025
Estimated completion	31 July 2025
Sites	1 location across Spain

Drugs / interventions tested

Face-to-face standard treatment
Telematic Support

Conditions studied

High-risk Infants — all drugs for High-risk Infants →

Sponsor

Universidad de Granada — full company profile →

Who can join

Adults 3 Months to 12 Months, any sex, with High-risk Infants. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to evaluate the effects of early intervention support sessions via video conferencing as an adjuvant option to motor development on infants at risk of neurodevelopmental delays or disorders.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Universidad de Granada trials

Trials by the same sponsor.

NCT07497698 — Saffron Extract Supplementation and Sleep Quality in Middle-Aged Adults · NA · recruiting
NCT07528924 — TuJugling: Comparing Two Juggling Learning Methods in College Students · NA · recruiting
NCT07388134 — Virtual Reality Based High-intensity Interval Training in Chronic Low Back Pain · NA · active not recruiting
NCT07494916 — Effects of Functional Task Training on Muscle Health and Function in Older Adults With Sarcopenia · NA · active not recruiting
NCT06518200 — Preventing Breast Cancer Therapy-related Cardiovascular Toxicity With a Daily-adapted Program With Mhealth Support · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06608576 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Universidad de Granada
Last refreshed: 23 September 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06608576.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing